ad981
Small moleculeexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 21, 2022 (NCT05448443)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05448443 | Phase 2 | Jun 21, 2022 | Apnimed, Inc., Istituto Auxologico Italiano, STM Pharma PRO srl, University of Florence, VIS Ethic Research Srl |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apnimed, Inc. | For profit | 1 | 0 | 1 | 2022 |
| Istituto Auxologico Italiano | Academic/Hospital | 1 | 1 | 1 | 2022 |
| STM Pharma PRO srl | For profit | 1 | 0 | 1 | 2022 |
| University of Florence | Academic/Hospital | 1 | 0 | 1 | 2022 |
| VIS Ethic Research Srl | For profit | 1 | 0 | 1 | 2022 |
5 organizations
Page 1 / 1